Zobrazeno 1 - 10
of 649
pro vyhledávání: '"DIRK RADES"'
Autor:
Christian Idel, Jonas Fleckner, Kirstin Plötze-Martin, Lotte Werner, Dirk Rades, Marie-Nicole Theodoraki, Linda Hofmann, Diana Huber, Anke Leichtle, Thomas K. Hoffmann, Karl-Ludwig Bruchhage, Ralph Pries
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-13 (2024)
Abstract Background Head and neck squamous cell carcinoma (HNSCC) represents a common and heterogeneous malignancy of the oral cavity, pharynx and larynx. Surgery and radio(chemo)therapy are the standard treatment options and also have great influenc
Externí odkaz:
https://doaj.org/article/00d90afcd16e4cecbcf18e983b6db96a
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
IntroductionTumor budding (TB) refers to the presence of small clusters of tumor cells at the invasive front of a malignant tumor. Single tumor cell invasion (SCI) is an extreme variant of TB, in which individual loose tumor cells are present at the
Externí odkaz:
https://doaj.org/article/fdf2e2dc302f433f86222746392e6b9c
Publikováno v:
Journal of Contemporary Brachytherapy, Vol 15, Iss 3, Pp 159-165 (2023)
Externí odkaz:
https://doaj.org/article/08b2b5c9c96c4ae8987ca18235b0d52c
Autor:
Dirk Rades, Inga Zwaan, Jon Cacicedo, Karl L. Bruchhage, Samer G. Hakim, Denise Olbrich, Steven E. Schild, Soeren Tvilsted, Stefan Janssen
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-9 (2022)
Abstract Background Radiotherapy of head-and-neck cancer (SCCHN) is often associated with acute toxicity. In a previous trial, daily reminders by staff members to perform skin care resulted in less dermatitis. This randomized trial investigated wheth
Externí odkaz:
https://doaj.org/article/28daba2668bd4fde9445536e81f3148d
Publikováno v:
Radiation Oncology, Vol 17, Iss 1, Pp 1-8 (2022)
Abstract Background A previous score predicted death ≤ 2 months following radiotherapy for MSCC. For patients with a high probability of early death, best supportive care was recommended. However, some of these patients may benefit from radiotherap
Externí odkaz:
https://doaj.org/article/e466e276bb474c40b8cf7c3635514954
Autor:
Charlotte Pfaffendorf, Reinhard Vonthein, Katja Krockenberger-Ziegler, Kathrin Dellas, Andreas Schreiber, Dorit Uhlemann, Stefan Dinges, Florian Würschmidt, Peter Andreas, Evelyn Weinstrauch, Kirsten Eilf, Dirk Rades, Ulrike Höller, Stephanie E. Combs, Renata Kazmierczak, Fabian Fehlauer, Ulrike Schreck, Jörg Zimmer, Jürgen Dunst, David Krug
Publikováno v:
Breast, Vol 64, Iss , Pp 136-142 (2022)
Purpose: To analyze long-term results of two multicenter prospective single-arm trials (ARO-2010-01 and ARO-2013-04) investigating adjuvant hypofractionated radiotherapy (HF) with simultaneous integrated boost (SIB) after breast-conserving surgery (B
Externí odkaz:
https://doaj.org/article/d300223b219549cebd4511bb1cc231f4
Autor:
Samer George Hakim, Clara Taubitz, Steffen Hoppe, Daniel Steller, Dirk Rades, Julika Ribbat-Idel, Ubai Alsharif, Mohamed Falougy
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
The epithelial-mesenchymal transition (EMT) is a biological mechanism in multiple pathophysiological diseases. Related alterations in cadherin expression play a crucial role in carcinogenesis, progression, angiogenesis, and immune response. EMT cells
Externí odkaz:
https://doaj.org/article/e6b5ba45d8544f709d2198b76bec8e85
Autor:
Dirk Rades, Carlos A. Narvaez, Liesa Dziggel, Stefan Janssen, Denise Olbrich, Soeren Tvilsted, Troels W. Kjaer
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-6 (2021)
Abstract Background Most breast cancer patients with non-metastatic disease receive adjuvant local or loco-regional radiotherapy. To be scheduled for irradiation may cause distress and fears that can lead to sleep disorders. Few reports focused on sl
Externí odkaz:
https://doaj.org/article/2393610ccc494511b2786f0ba65014df
Autor:
Dirk Rades, Jaspar Witteler, Denise Olbrich, Peter Trillenberg, Steven E. Schild, Soeren Tvilsted, Troels W. Kjaer
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-7 (2021)
Abstract Background Gliomas are often associated with symptoms including seizures. Most patients with high-grade gliomas are treated with radiotherapy or radio-chemotherapy. Since irradiation causes inflammation, it may initially aggravate symptoms.
Externí odkaz:
https://doaj.org/article/aeac2c53fdad4bf7862434a31edc378c
Autor:
Leonie Johannwerner, Elisa M. Werner, Oliver Blanck, Stefan Janssen, Florian Cremers, Nathan Y. Yu, Dirk Rades
Publikováno v:
Biology, Vol 12, Iss 5, p 655 (2023)
In Radiation Therapy Oncology Group 90-05, the maximum tolerated dose of single-fraction radiosurgery (SRS) for brain metastases of 21–30 mm was 18 Gy (biologically effective dose (BED) 45 Gy12). Since the patients in this study received prior brai
Externí odkaz:
https://doaj.org/article/add3d2f076544f31bd24e755b95f5a98